The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials - PubMed (original) (raw)
Meta-Analysis
The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials
Hyun Choi et al. Eur J Emerg Med. 2014 Feb.
Abstract
Objective: The objective of this study was to assess the efficacy and tolerability of intravenous magnesium for the treatment of acute migraine in adults.
Selection criteria: Double-blind, randomized controlled trials of intravenous magnesium for acute migraine in adults.
Data sources: Cochrane Central Register of Controlled Trials, Medline, EMBASE, CINAHL, National Research Register Archive, ACP Journal Club, the US Government's Clinical Trial Database, Conference Proceedings, and other sources.
Results: Overall, 1203 abstracts were reviewed and five randomized controlled trials totalling 295 patients were eligible for the meta-analyses. The percentage of patients who experienced relief from headache 30 min following treatment was 7% lower in the magnesium groups compared with the controls [pooled risk difference=-0.07, 95% confidence interval (CI)=-0.23 to 0.09]. The percentage of patients who experienced side-effects or adverse events was greater in the magnesium groups compared with controls by 37% (pooled risk difference=0.370, 95% CI=0.06-0.68). The percentage of patients who needed rescue analgesic medications was slightly lower in the control groups, but this was not significant (pooled risk difference=-0.021, 95% CI=-0.16 to 0.12).
Conclusion: The meta-analyses have failed to demonstrate a beneficial effect of intravenous magnesium in terms of reduction in pain relief in acute migraine in adults, showed no benefit in terms of the need for rescue medication and in fact have shown that patients treated with magnesium were significantly more likely to report side-effects/adverse events.
Similar articles
- A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. Cete Y, et al. Cephalalgia. 2005 Mar;25(3):199-204. doi: 10.1111/j.1468-2982.2004.00840.x. Cephalalgia. 2005. PMID: 15689195 Clinical Trial. - Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ. Corbo J, et al. Ann Emerg Med. 2001 Dec;38(6):621-7. doi: 10.1067/mem.2001.119424. Ann Emerg Med. 2001. PMID: 11719739 Clinical Trial. - A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, Chang E, Hochberg M, Campbell C, Aghera A, Valentin T, Paternoster J, Bijur P, Lipton RB, Gallagher EJ. Friedman BW, et al. Ann Emerg Med. 2008 Oct;52(4):399-406. doi: 10.1016/j.annemergmed.2007.09.027. Epub 2007 Nov 19. Ann Emerg Med. 2008. PMID: 18006188 Clinical Trial. - Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
Kelley NE, Tepper DE. Kelley NE, et al. Headache. 2012 Mar;52(3):467-82. doi: 10.1111/j.1526-4610.2012.02097.x. Headache. 2012. PMID: 22404708 Review.
Cited by
- Relationship between Magnesium Intake and Chronic Pain in U.S. Adults.
Tarleton EK, Kennedy AG, Rose GL, Littenberg B. Tarleton EK, et al. Nutrients. 2020 Jul 16;12(7):2104. doi: 10.3390/nu12072104. Nutrients. 2020. PMID: 32708577 Free PMC article. - Treatment of headache following triptan failure after successful triptan therapy.
Lenaerts ME, Couch JR Jr. Lenaerts ME, et al. Curr Treat Options Neurol. 2015 Jun;17(6):353. doi: 10.1007/s11940-015-0353-6. Curr Treat Options Neurol. 2015. PMID: 25962622 - Review on Headache Related to Dietary Supplements.
Ariyanfar S, Razeghi Jahromi S, Togha M, Ghorbani Z. Ariyanfar S, et al. Curr Pain Headache Rep. 2022 Mar;26(3):193-218. doi: 10.1007/s11916-022-01019-9. Epub 2022 Mar 7. Curr Pain Headache Rep. 2022. PMID: 35254637 Review. - Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency.
Fiorentini D, Cappadone C, Farruggia G, Prata C. Fiorentini D, et al. Nutrients. 2021 Mar 30;13(4):1136. doi: 10.3390/nu13041136. Nutrients. 2021. PMID: 33808247 Free PMC article. Review. - Targeting Glutamate Neurotoxicity through Dietary Manipulation: Potential Treatment for Migraine.
Martami F, Holton KF. Martami F, et al. Nutrients. 2023 Sep 12;15(18):3952. doi: 10.3390/nu15183952. Nutrients. 2023. PMID: 37764736 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical